A detailed history of Creative Planning transactions in Atrion Corp stock. As of the latest transaction made, Creative Planning holds 4,133 shares of ATRI stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,133
Previous 4,140 0.17%
Holding current value
$0
Previous $1.92 Million 2.61%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$381.09 - $495.99 $2,667 - $3,471
-7 Reduced 0.17%
4,133 $1.87 Million
Q1 2024

May 10, 2024

BUY
$308.3 - $463.55 $27,747 - $41,719
90 Added 2.22%
4,140 $1.92 Million
Q4 2023

Feb 14, 2024

BUY
$289.29 - $409.7 $46,864 - $66,371
162 Added 4.17%
4,050 $1.53 Million
Q3 2023

Nov 16, 2023

BUY
$401.2 - $581.79 $32,497 - $47,124
81 Added 2.13%
3,888 $1.61 Million
Q2 2023

Jul 21, 2023

BUY
$500.0 - $659.0 $2,500 - $3,295
5 Added 0.13%
3,807 $2.15 Million
Q1 2023

May 15, 2023

SELL
$565.0 - $694.87 $1,130 - $1,389
-2 Reduced 0.05%
3,802 $2.39 Million
Q4 2022

Feb 10, 2023

BUY
$551.1 - $688.5 $15,430 - $19,278
28 Added 0.74%
3,804 $2.13 Million
Q1 2022

May 16, 2022

BUY
$601.4 - $763.0 $1,202 - $1,526
2 Added 0.05%
3,776 $2.69 Million
Q1 2021

Apr 30, 2021

BUY
$619.2 - $736.0 $2,476 - $2,944
4 Added 0.11%
3,774 $2.42 Million
Q4 2020

Jan 29, 2021

BUY
$576.6 - $672.2 $3,459 - $4,033
6 Added 0.16%
3,770 $2.42 Million
Q1 2020

May 05, 2020

SELL
$615.5 - $751.4 $70,782 - $86,411
-115 Reduced 2.96%
3,764 $2.45 Million
Q1 2019

Apr 24, 2019

SELL
$709.9 - $885.4 $570,049 - $710,976
-803 Reduced 17.15%
3,879 $3.41 Million
Q2 2018

Jul 20, 2018

BUY
$568.25 - $635.8 $38,072 - $42,598
67 Added 1.45%
4,682 $2.81 Million
Q3 2017

Oct 17, 2017

BUY
$608.7 - $680.0 $2.81 Million - $3.14 Million
4,615
4,615 $3.1 Million

Others Institutions Holding ATRI

About ATRION CORP


  • Ticker ATRI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 1,785,990
  • Description
  • Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in vari...
More about ATRI
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.